ReP USP - Resultado da busca

Artigo de periodico
Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism (2021)
Neto-Neves, Evandro Manoel; Sousa-Santos, Ozelia; Ferraz, Karina C.; Portella, Rafael L.; Sertorio, Jonas T.; Tanus-Santos, José Eduardo
Fonte: Nitric Oxide. Unidade: FMRP
Assuntos: DOENÇA AGUDA, TROMBOFLEBITE, ANTIOXIDANTES, VENTRÍCULO CARDÍACO, HIPERTENSÃO PULMONAR, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NETO-NEVES, Evandro Manoel et al. Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism. Nitric Oxide, v. 115, p. 23-29, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2021.06.004. Acesso em: 01 nov. 2024.
APA
Neto-Neves, E. M., Sousa-Santos, O., Ferraz, K. C., Portella, R. L., Sertorio, J. T., & Tanus-Santos, J. E. (2021). Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism. Nitric Oxide, 115, 23-29. doi:10.1016/j.niox.2021.06.004
NLM
Neto-Neves EM, Sousa-Santos O, Ferraz KC, Portella RL, Sertorio JT, Tanus-Santos JE. Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism [Internet]. Nitric Oxide. 2021 ; 115 23-29.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.niox.2021.06.004
Vancouver
Neto-Neves EM, Sousa-Santos O, Ferraz KC, Portella RL, Sertorio JT, Tanus-Santos JE. Nitrite and tempol combination promotes synergic effects and alleviates right ventricular wall stress during acute pulmonary thromboembolism [Internet]. Nitric Oxide. 2021 ; 115 23-29.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.niox.2021.06.004
Artigo de periodico
Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension (2021)
Guimarães, Danielle Aparecida; Batista, Rose Inês Matos ; Tanus-Santos, José Eduardo
Fonte: Basic & Clinical Pharmacology & Toxicology. Unidade: FMRP
Assuntos: FÁRMACOS (SISTEMA CARDIOVASCULAR), ARTÉRIAS, HIPERTENSÃO, HIPERTROFIA VENTRICULAR ESQUERDA, NITRATOS, ÓXIDO NÍTRICO, ESTRESSE OXIDATIVO, SISTEMA RENINA-ANGIOTENSINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Danielle Aparecida e BATISTA, Rose Inês Matos e TANUS-SANTOS, José Eduardo. Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension. Basic & Clinical Pharmacology & Toxicology, v. 128, n. 1, p. 9-17, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcpt.13474. Acesso em: 01 nov. 2024.
APA
Guimarães, D. A., Batista, R. I. M., & Tanus-Santos, J. E. (2021). Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension. Basic & Clinical Pharmacology & Toxicology, 128( 1), 9-17. doi:10.1111/bcpt.13474
NLM
Guimarães DA, Batista RIM, Tanus-Santos JE. Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension [Internet]. Basic & Clinical Pharmacology & Toxicology. 2021 ; 128( 1): 9-17.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/bcpt.13474
Vancouver
Guimarães DA, Batista RIM, Tanus-Santos JE. Nitrate and nitrite-based therapy to attenuate cardiovascular remodelling in arterial hypertension [Internet]. Basic & Clinical Pharmacology & Toxicology. 2021 ; 128( 1): 9-17.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/bcpt.13474
Artigo de periodico
NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia (2021)
Pereira, Daniela A.; Sandrim, Valeria C.; Palei, Ana C.; Amaral, Lorena M.; Belo, Vanessa A.; Lacchini, Riccardo ; Cavalli, Ricardo de Carvalho; Tanus-Santos, José Eduardo ; Luizon, Marcelo R.
Fonte: Pharmacogenomics. Unidades: EERP, FMRP
Assuntos: FÁRMACOS (SISTEMA CARDIOVASCULAR), CITOCINAS, ÓXIDO NÍTRICO, POLIMORFISMO, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Daniela A. et al. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics, v. 22, n. 8, p. 451-464, 2021Tradução . . Disponível em: https://doi.org/10.2217/pgs-2021-0006. Acesso em: 01 nov. 2024.
APA
Pereira, D. A., Sandrim, V. C., Palei, A. C., Amaral, L. M., Belo, V. A., Lacchini, R., et al. (2021). NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics, 22( 8), 451-464. doi:10.2217/pgs-2021-0006
NLM
Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli R de C, Tanus-Santos JE, Luizon MR. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2021 ; 22( 8): 451-464.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2217/pgs-2021-0006
Vancouver
Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli R de C, Tanus-Santos JE, Luizon MR. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2021 ; 22( 8): 451-464.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2217/pgs-2021-0006
Artigo de periodico
Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol (2021)
Paula, Gustavo Henrique Oliveira de; Pereira, Daniela A.; Pinheiro, Lucas Cezar ; Ferreira, Graziele Cristina ; Garcia, Waynice Neiva de Paula ; Garcia, Luis Vicente ; Lacchini, Riccardo ; Luizon, Marcelo R.; Tanus-Santos, José Eduardo
Fonte: Basic & Clinical Pharmacology & Toxicology. Unidades: FMRP, EERP
Assuntos: ANESTÉSICOS INTRAVENOSOS, ESTUDOS TRANSVERSAIS, GENÓTIPOS, HAPLOTIPOS, HIPOTENSÃO, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAULA, Gustavo Henrique Oliveira de et al. Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol. Basic & Clinical Pharmacology & Toxicology, v. 130, n. 2, p. 277-287, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcpt.13691. Acesso em: 01 nov. 2024.
APA
Paula, G. H. O. de, Pereira, D. A., Pinheiro, L. C., Ferreira, G. C., Garcia, W. N. de P., Garcia, L. V., et al. (2021). Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol. Basic & Clinical Pharmacology & Toxicology, 130( 2), 277-287. doi:10.1111/bcpt.13691
NLM
Paula GHO de, Pereira DA, Pinheiro LC, Ferreira GC, Garcia WN de P, Garcia LV, Lacchini R, Luizon MR, Tanus-Santos JE. Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol [Internet]. Basic & Clinical Pharmacology & Toxicology. 2021 ; 130( 2): 277-287.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/bcpt.13691
Vancouver
Paula GHO de, Pereira DA, Pinheiro LC, Ferreira GC, Garcia WN de P, Garcia LV, Lacchini R, Luizon MR, Tanus-Santos JE. Gene–gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol [Internet]. Basic & Clinical Pharmacology & Toxicology. 2021 ; 130( 2): 277-287.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/bcpt.13691
Artigo de periodico
Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II (2021)
Pinheiro, Lucas Cezar ; Oliveira-Paula, Gustavo Henrique; Ferreira, Graziele Cristina ; Paula, Tiago Dal-Cin de; Duarte, Diego Ângelo; Costa Neto, Cláudio Miguel; Tanus-Santos, José Eduardo
Fonte: Redox Report. Unidades: EERP, FMRP
Assuntos: ANGIOTENSINA II, ÓXIDO NÍTRICO, NITRITOS, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHEIRO, Lucas Cezar et al. Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II. Redox Report, v. 38, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.redox.2020.101769. Acesso em: 01 nov. 2024.
APA
Pinheiro, L. C., Oliveira-Paula, G. H., Ferreira, G. C., Paula, T. D. -C. de, Duarte, D. Â., Costa Neto, C. M., & Tanus-Santos, J. E. (2021). Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II. Redox Report, 38, 1-11. doi:10.1016/j.redox.2020.101769
NLM
Pinheiro LC, Oliveira-Paula GH, Ferreira GC, Paula TD-C de, Duarte DÂ, Costa Neto CM, Tanus-Santos JE. Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II [Internet]. Redox Report. 2021 ; 38 1-11.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.redox.2020.101769
Vancouver
Pinheiro LC, Oliveira-Paula GH, Ferreira GC, Paula TD-C de, Duarte DÂ, Costa Neto CM, Tanus-Santos JE. Oral nitrite treatment increases S-nitrosylation of vascular protein kinase C and attenuates the responses to angiotensin II [Internet]. Redox Report. 2021 ; 38 1-11.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.redox.2020.101769
Artigo de periodico
Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis (2020)
Valente, Flavia Mariana; Andrade, Days Oliveira de; Cosenso-Martin, Luciana Neves; Cesarino, Cláudia Bernardi; Guimarães, Sérgio Mussi; Guimarães, Victor Beneditti; Lacchini, Riccardo ; Tanus-Santos, José Eduardo ; Yugar-Toledo, Juan Carlos; Vilela-Martin, José Fernando
Fonte: BMC Cardiovascular Disorders. Unidades: EERP, FMRP
Assuntos: METALOPROTEINASES, BIOMARCADORES, CARDIOLOGIA, HIPERTENSÃO, FISIOPATOLOGIA, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALENTE, Flavia Mariana et al. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis. BMC Cardiovascular Disorders, v. 20, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12872-020-01412-5. Acesso em: 01 nov. 2024.
APA
Valente, F. M., Andrade, D. O. de, Cosenso-Martin, L. N., Cesarino, C. B., Guimarães, S. M., Guimarães, V. B., et al. (2020). Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis. BMC Cardiovascular Disorders, 20, 1-7. doi:10.1186/s12872-020-01412-5
NLM
Valente FM, Andrade DO de, Cosenso-Martin LN, Cesarino CB, Guimarães SM, Guimarães VB, Lacchini R, Tanus-Santos JE, Yugar-Toledo JC, Vilela-Martin JF. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis [Internet]. BMC Cardiovascular Disorders. 2020 ; 20 1-7.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/s12872-020-01412-5
Vancouver
Valente FM, Andrade DO de, Cosenso-Martin LN, Cesarino CB, Guimarães SM, Guimarães VB, Lacchini R, Tanus-Santos JE, Yugar-Toledo JC, Vilela-Martin JF. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis [Internet]. BMC Cardiovascular Disorders. 2020 ; 20 1-7.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/s12872-020-01412-5
Artigo de periodico
Chronic ethanol consumption increases reactive oxygen species generation and the synthesis of pro-inflammatory proteins in the heart through TNFR1-dependent mechanisms (2019)
Nakashima, Marcelo A.; Silva, Carla Beatriz Pereira da ; Gonzaga, Natália de Almeida; Simplicio, Janaina A.; Omoto, Ana Carolina Mieko ; Tirapelli, Luis Fernando; Tanus-Santos, José Eduardo; Tirapelli, Carlos Renato
Fonte: Cytokine. Unidades: FMRP, EERP
Assuntos: ESTRESSE OXIDATIVO, ETANOL, CITOTOXINAS, SEPSE, INTERLEUCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAKASHIMA, Marcelo A. et al. Chronic ethanol consumption increases reactive oxygen species generation and the synthesis of pro-inflammatory proteins in the heart through TNFR1-dependent mechanisms. Cytokine, v. 121, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.cyto.2019.154734. Acesso em: 01 nov. 2024.
APA
Nakashima, M. A., Silva, C. B. P. da, Gonzaga, N. de A., Simplicio, J. A., Omoto, A. C. M., Tirapelli, L. F., et al. (2019). Chronic ethanol consumption increases reactive oxygen species generation and the synthesis of pro-inflammatory proteins in the heart through TNFR1-dependent mechanisms. Cytokine, 121. doi:10.1016/j.cyto.2019.154734
NLM
Nakashima MA, Silva CBP da, Gonzaga N de A, Simplicio JA, Omoto ACM, Tirapelli LF, Tanus-Santos JE, Tirapelli CR. Chronic ethanol consumption increases reactive oxygen species generation and the synthesis of pro-inflammatory proteins in the heart through TNFR1-dependent mechanisms [Internet]. Cytokine. 2019 ; 121[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.cyto.2019.154734
Vancouver
Nakashima MA, Silva CBP da, Gonzaga N de A, Simplicio JA, Omoto ACM, Tirapelli LF, Tanus-Santos JE, Tirapelli CR. Chronic ethanol consumption increases reactive oxygen species generation and the synthesis of pro-inflammatory proteins in the heart through TNFR1-dependent mechanisms [Internet]. Cytokine. 2019 ; 121[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.cyto.2019.154734
Artigo de periodico
Sodium nitrite improves hypertension-induced myocardial dysfunction by mechanisms involving cardiac S-nitrosylation (2019)
Neto-Neves, Evandro M.; Pinheiro, Lucas Cézar ; Nogueira, Renato Corrêa; Portella, Rafael L.; Batista, Rose Inês Matos ; Tanus-Santos, José Eduardo
Fonte: Journal of Molecular and Cellular Cardiology. Unidades: EERP, FMRP
Assunto: NITRITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NETO-NEVES, Evandro M. et al. Sodium nitrite improves hypertension-induced myocardial dysfunction by mechanisms involving cardiac S-nitrosylation. Journal of Molecular and Cellular Cardiology, v. 134, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.yjmcc.2019.06.012. Acesso em: 01 nov. 2024.
APA
Neto-Neves, E. M., Pinheiro, L. C., Nogueira, R. C., Portella, R. L., Batista, R. I. M., & Tanus-Santos, J. E. (2019). Sodium nitrite improves hypertension-induced myocardial dysfunction by mechanisms involving cardiac S-nitrosylation. Journal of Molecular and Cellular Cardiology, 134. doi:10.1016/j.yjmcc.2019.06.012
NLM
Neto-Neves EM, Pinheiro LC, Nogueira RC, Portella RL, Batista RIM, Tanus-Santos JE. Sodium nitrite improves hypertension-induced myocardial dysfunction by mechanisms involving cardiac S-nitrosylation [Internet]. Journal of Molecular and Cellular Cardiology. 2019 ; 134[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.yjmcc.2019.06.012
Vancouver
Neto-Neves EM, Pinheiro LC, Nogueira RC, Portella RL, Batista RIM, Tanus-Santos JE. Sodium nitrite improves hypertension-induced myocardial dysfunction by mechanisms involving cardiac S-nitrosylation [Internet]. Journal of Molecular and Cellular Cardiology. 2019 ; 134[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.yjmcc.2019.06.012
Artigo de periodico
Pharmacogenomics and hypertension: current insights (2019)
Oliveira-Paula, Gustavo H.; Pereira, Sherliane Carla ; Tanus-Santos, José Eduardo ; Lacchini, Riccardo
Fonte: Pharmacogenomics and Personalized Medicine. Unidades: FMRP, EERP
Assuntos: GENES, HIPERTENSÃO, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-PAULA, Gustavo H. et al. Pharmacogenomics and hypertension: current insights. Pharmacogenomics and Personalized Medicine, v. 2019, n. 12, p. 341-359, 2019Tradução . . Disponível em: https://doi.org/10.2147/PGPM.S230201. Acesso em: 01 nov. 2024.
APA
Oliveira-Paula, G. H., Pereira, S. C., Tanus-Santos, J. E., & Lacchini, R. (2019). Pharmacogenomics and hypertension: current insights. Pharmacogenomics and Personalized Medicine, 2019( 12), 341-359. doi:10.2147/PGPM.S230201
NLM
Oliveira-Paula GH, Pereira SC, Tanus-Santos JE, Lacchini R. Pharmacogenomics and hypertension: current insights [Internet]. Pharmacogenomics and Personalized Medicine. 2019 ; 2019( 12): 341-359.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2147/PGPM.S230201
Vancouver
Oliveira-Paula GH, Pereira SC, Tanus-Santos JE, Lacchini R. Pharmacogenomics and hypertension: current insights [Internet]. Pharmacogenomics and Personalized Medicine. 2019 ; 2019( 12): 341-359.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2147/PGPM.S230201
Artigo de periodico
Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions (2018)
Luizon, Marcelo Rizzatti; Pereira, Daniela A.; Tanus-Santos, José Eduardo
Fonte: Pharmacogenomics. Unidade: FMRP
Assuntos: ÓXIDO NÍTRICO, POLIMORFISMO, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZON, Marcelo Rizzatti e PEREIRA, Daniela A. e TANUS-SANTOS, José Eduardo. Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions. Pharmacogenomics, v. 19, n. 18, p. 1423-1435, 2018Tradução . . Disponível em: https://doi.org/10.2217/pgs-2018-0098. Acesso em: 01 nov. 2024.
APA
Luizon, M. R., Pereira, D. A., & Tanus-Santos, J. E. (2018). Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions. Pharmacogenomics, 19( 18), 1423-1435. doi:10.2217/pgs-2018-0098
NLM
Luizon MR, Pereira DA, Tanus-Santos JE. Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions [Internet]. Pharmacogenomics. 2018 ; 19( 18): 1423-1435.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2217/pgs-2018-0098
Vancouver
Luizon MR, Pereira DA, Tanus-Santos JE. Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions [Internet]. Pharmacogenomics. 2018 ; 19( 18): 1423-1435.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2217/pgs-2018-0098
Artigo de periodico
Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil (2018)
Lacchini, Riccardo ; Muniz, Jaqueline Jóice; Nobre, Yuri Túlio D. Andrez; Cologna, Adauto José; Martins, Antonio Carlos Pereira; Tanus-Santos, José Eduardo
Fonte: The Pharmacogenomics Journal. Unidades: EERP, FMRP
Assuntos: POLIMORFISMO, DISFUNÇÃO ERÉTIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LACCHINI, Riccardo et al. Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil. The Pharmacogenomics Journal, v. 18, n. 2, p. 238-244, 2018Tradução . . Disponível em: https://doi.org/10.1038/tpj.2017.2. Acesso em: 01 nov. 2024.
APA
Lacchini, R., Muniz, J. J., Nobre, Y. T. D. A., Cologna, A. J., Martins, A. C. P., & Tanus-Santos, J. E. (2018). Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil. The Pharmacogenomics Journal, 18( 2), 238-244. doi:10.1038/tpj.2017.2
NLM
Lacchini R, Muniz JJ, Nobre YTDA, Cologna AJ, Martins ACP, Tanus-Santos JE. Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil [Internet]. The Pharmacogenomics Journal. 2018 ; 18( 2): 238-244.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1038/tpj.2017.2
Vancouver
Lacchini R, Muniz JJ, Nobre YTDA, Cologna AJ, Martins ACP, Tanus-Santos JE. Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil [Internet]. The Pharmacogenomics Journal. 2018 ; 18( 2): 238-244.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1038/tpj.2017.2
Artigo de periodico
The potential of stimulating nitric oxide formation in the treatment of hypertension (2017)
Pinheiro, Lucas C.; Tanus-Santos, José Eduardo; Castro, Michele Mazzaron de
Fonte: Expert Opinion on Therapeutic Targets. Unidade: FMRP
Assuntos: HIPERTENSÃO, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHEIRO, Lucas C. e TANUS-SANTOS, José Eduardo e CASTRO, Michele Mazzaron de. The potential of stimulating nitric oxide formation in the treatment of hypertension. Expert Opinion on Therapeutic Targets, v. 21, n. 5, p. 543-556, 2017Tradução . . Disponível em: https://doi.org/10.1080/14728222.2017.1310840. Acesso em: 01 nov. 2024.
APA
Pinheiro, L. C., Tanus-Santos, J. E., & Castro, M. M. de. (2017). The potential of stimulating nitric oxide formation in the treatment of hypertension. Expert Opinion on Therapeutic Targets, 21( 5), 543-556. doi:10.1080/14728222.2017.1310840
NLM
Pinheiro LC, Tanus-Santos JE, Castro MM de. The potential of stimulating nitric oxide formation in the treatment of hypertension [Internet]. Expert Opinion on Therapeutic Targets. 2017 ; 21( 5): 543-556.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1080/14728222.2017.1310840
Vancouver
Pinheiro LC, Tanus-Santos JE, Castro MM de. The potential of stimulating nitric oxide formation in the treatment of hypertension [Internet]. Expert Opinion on Therapeutic Targets. 2017 ; 21( 5): 543-556.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1080/14728222.2017.1310840
Artigo de periodico-carta/editorial
Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal] (2017)
Amaral, Jefferson Henrich; Tanus-Santos, José Eduardo
Fonte: Neurogastroenterology & Motility. Unidade: FMRP
Assuntos: DOENÇAS VASCULARES, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, Jefferson Henrich e TANUS-SANTOS, José Eduardo. Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal]. Neurogastroenterology & Motility. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1111/nmo.12988. Acesso em: 01 nov. 2024. , 2017
APA
Amaral, J. H., & Tanus-Santos, J. E. (2017). Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal]. Neurogastroenterology & Motility. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1111/nmo.12988
NLM
Amaral JH, Tanus-Santos JE. Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal] [Internet]. Neurogastroenterology & Motility. 2017 ; 29( 2):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/nmo.12988
Vancouver
Amaral JH, Tanus-Santos JE. Mechanisms contributing to increased cardiovascular risk in patients taking proton pump inhibitors. [Cartal] [Internet]. Neurogastroenterology & Motility. 2017 ; 29( 2):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/nmo.12988
Artigo de periodico
Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy (2017)
Luizon, Marcelo Rizzatti; Palei, Ana Carolina Taveiros; Belo, V. A.; Amaral, L. M.; Lacchini, Riccardo ; Duarte, Geraldo; Cavalli, Ricardo de Carvalho; Sandrim, Valéria Cristina; Tanus-Santos, José Eduardo
Fonte: The Pharmacogenomics Journal. Unidades: EERP, FMRP
Assuntos: POLIMORFISMO, FÁRMACOS (SISTEMA CARDIOVASCULAR), HIPERTENSÃO NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZON, Marcelo Rizzatti et al. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, v. 17, n. 5, p. 427-434, 2017Tradução . . Disponível em: https://doi.org/10.1038/tpj.2016.35. Acesso em: 01 nov. 2024.
APA
Luizon, M. R., Palei, A. C. T., Belo, V. A., Amaral, L. M., Lacchini, R., Duarte, G., et al. (2017). Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, 17( 5), 427-434. doi:10.1038/tpj.2016.35
NLM
Luizon MR, Palei ACT, Belo VA, Amaral LM, Lacchini R, Duarte G, Cavalli R de C, Sandrim VC, Tanus-Santos JE. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2017 ; 17( 5): 427-434.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1038/tpj.2016.35
Vancouver
Luizon MR, Palei ACT, Belo VA, Amaral LM, Lacchini R, Duarte G, Cavalli R de C, Sandrim VC, Tanus-Santos JE. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2017 ; 17( 5): 427-434.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1038/tpj.2016.35
Artigo de periodico
Association of mineralocorticoid receptor polymorphism l180V with left ventricular hypertrophy in resistant hypertension (2016)
Ritter, Alessandra Mileni Versuti; Fontana, Vanessa; Faria, Ana Paula Cabral de; Modolo, Rodrigo; Barbaro, Natália R.; Sabbatini, Andréa R.; Peres, Heverton; Biagi, Celso; Silva, Pâmela; Lopes, Paulo César; Tanus-Santos, José Eduardo; Coelho, Eduardo Barbosa; Moreno, Heitor
Fonte: American Journal of Hypertension. Unidade: FMRP
Assuntos: ALDOSTERONA, PRESSÃO SANGUÍNEA, POLIMORFISMO, HIPERTENSÃO, HIPERTROFIA VENTRICULAR ESQUERDA, SISTEMA CARDIOVASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RITTER, Alessandra Mileni Versuti et al. Association of mineralocorticoid receptor polymorphism l180V with left ventricular hypertrophy in resistant hypertension. American Journal of Hypertension, v. 29, n. 2, p. 245-250, 2016Tradução . . Disponível em: https://doi.org/10.1093/ajh/hpv070. Acesso em: 01 nov. 2024.
APA
Ritter, A. M. V., Fontana, V., Faria, A. P. C. de, Modolo, R., Barbaro, N. R., Sabbatini, A. R., et al. (2016). Association of mineralocorticoid receptor polymorphism l180V with left ventricular hypertrophy in resistant hypertension. American Journal of Hypertension, 29( 2), 245-250. doi:10.1093/ajh/hpv070
NLM
Ritter AMV, Fontana V, Faria APC de, Modolo R, Barbaro NR, Sabbatini AR, Peres H, Biagi C, Silva P, Lopes PC, Tanus-Santos JE, Coelho EB, Moreno H. Association of mineralocorticoid receptor polymorphism l180V with left ventricular hypertrophy in resistant hypertension [Internet]. American Journal of Hypertension. 2016 ; 29( 2): 245-250.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1093/ajh/hpv070
Vancouver
Ritter AMV, Fontana V, Faria APC de, Modolo R, Barbaro NR, Sabbatini AR, Peres H, Biagi C, Silva P, Lopes PC, Tanus-Santos JE, Coelho EB, Moreno H. Association of mineralocorticoid receptor polymorphism l180V with left ventricular hypertrophy in resistant hypertension [Internet]. American Journal of Hypertension. 2016 ; 29( 2): 245-250.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1093/ajh/hpv070
Artigo de periodico
Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression (2016)
Luizon, Marcelo R.; Caldeira dias, Mayara; Deffune, Elenice; Fernandes, Karla S.; Cavalli, Ricardo de Carvalho; Tanus-Santos, José Eduardo; Sandrim, Valéria Cristina
Fonte: Pharmacogenomics. Unidade: FMRP
Assuntos: FÁRMACOS (SISTEMA CARDIOVASCULAR), ENDOTÉLIO VASCULAR, EXPRESSÃO GÊNICA, CÉLULAS ENDOTELIAIS, PLASMA, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZON, Marcelo R. et al. Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression. Pharmacogenomics, v. 17, n. 10, p. 1121-1127, 2016Tradução . . Disponível em: https://doi.org/10.2217/pgs-2016-0033. Acesso em: 01 nov. 2024.
APA
Luizon, M. R., Caldeira dias, M., Deffune, E., Fernandes, K. S., Cavalli, R. de C., Tanus-Santos, J. E., & Sandrim, V. C. (2016). Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression. Pharmacogenomics, 17( 10), 1121-1127. doi:10.2217/pgs-2016-0033
NLM
Luizon MR, Caldeira dias M, Deffune E, Fernandes KS, Cavalli R de C, Tanus-Santos JE, Sandrim VC. Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression [Internet]. Pharmacogenomics. 2016 ; 17( 10): 1121-1127.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2217/pgs-2016-0033
Vancouver
Luizon MR, Caldeira dias M, Deffune E, Fernandes KS, Cavalli R de C, Tanus-Santos JE, Sandrim VC. Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression [Internet]. Pharmacogenomics. 2016 ; 17( 10): 1121-1127.[citado 2024 nov. 01 ] Available from: https://doi.org/10.2217/pgs-2016-0033
Artigo de periodico
Plasma from pre-eclamptic patients induces the expression of the anti-angiogenic miR-195-5p in endothelial cells (2016)
Sandrim, Valéria Cristina; Dias, Mayara Caldeira; Bovolato, Ana Lívia de Carvalho; Tanus-Santos, José Eduardo; Deffune, Elenice; Cavalli, Ricardo de Carvalho
Fonte: Journal of Cellular and Molecular Medicine. Unidade: FMRP
Assuntos: PRÉ-ECLÂMPSIA, EXPRESSÃO GÊNICA, CÉLULAS ENDOTELIAIS, NEOVASCULARIZAÇÃO PATOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDRIM, Valéria Cristina et al. Plasma from pre-eclamptic patients induces the expression of the anti-angiogenic miR-195-5p in endothelial cells. Journal of Cellular and Molecular Medicine, v. 20, n. 6, p. 1198-1200, 2016Tradução . . Disponível em: https://doi.org/10.1111/jcmm.12767. Acesso em: 01 nov. 2024.
APA
Sandrim, V. C., Dias, M. C., Bovolato, A. L. de C., Tanus-Santos, J. E., Deffune, E., & Cavalli, R. de C. (2016). Plasma from pre-eclamptic patients induces the expression of the anti-angiogenic miR-195-5p in endothelial cells. Journal of Cellular and Molecular Medicine, 20( 6), 1198-1200. doi:10.1111/jcmm.12767
NLM
Sandrim VC, Dias MC, Bovolato AL de C, Tanus-Santos JE, Deffune E, Cavalli R de C. Plasma from pre-eclamptic patients induces the expression of the anti-angiogenic miR-195-5p in endothelial cells [Internet]. Journal of Cellular and Molecular Medicine. 2016 ; 20( 6): 1198-1200.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/jcmm.12767
Vancouver
Sandrim VC, Dias MC, Bovolato AL de C, Tanus-Santos JE, Deffune E, Cavalli R de C. Plasma from pre-eclamptic patients induces the expression of the anti-angiogenic miR-195-5p in endothelial cells [Internet]. Journal of Cellular and Molecular Medicine. 2016 ; 20( 6): 1198-1200.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/jcmm.12767
Artigo de periodico
Longitudinal assessment of maternal-fetal Doppler parameters and maternal plasma level of matrix metalloproteinases 2 and 9 (2016)
Jorge Neto, Salim Demétrio; Machado, Jackeline Souza Rangel; Araújo Júnior, Edward; Palei, Ana Carolina Taveiros; Amaral, Lorena Machado; Tanus-Santos, José Eduardo; Marcolin, Alessandra Cristina; Duarte, Geraldo; Sandrim, Valeria Cristina; Cavalli, Ricardo de Carvalho
Fonte: The Journal of Maternal-Fetal and Neonatal Medicine. Unidade: FMRP
Assuntos: BIOMARCADORES, ULTRASSONOGRAFIA DOPPLER, METALOPROTEINASES, GRAVIDEZ, ULTRASSONOGRAFIA PRÉ-NATAL, ÚTERO, DIAGNÓSTICO POR IMAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JORGE NETO, Salim Demétrio et al. Longitudinal assessment of maternal-fetal Doppler parameters and maternal plasma level of matrix metalloproteinases 2 and 9. The Journal of Maternal-Fetal and Neonatal Medicine, v. 29, n. 24, p. 3967-3970, 2016Tradução . . Disponível em: https://doi.org/10.3109/14767058.2016.1152247. Acesso em: 01 nov. 2024.
APA
Jorge Neto, S. D., Machado, J. S. R., Araújo Júnior, E., Palei, A. C. T., Amaral, L. M., Tanus-Santos, J. E., et al. (2016). Longitudinal assessment of maternal-fetal Doppler parameters and maternal plasma level of matrix metalloproteinases 2 and 9. The Journal of Maternal-Fetal and Neonatal Medicine, 29( 24), 3967-3970. doi:10.3109/14767058.2016.1152247
NLM
Jorge Neto SD, Machado JSR, Araújo Júnior E, Palei ACT, Amaral LM, Tanus-Santos JE, Marcolin AC, Duarte G, Sandrim VC, Cavalli R de C. Longitudinal assessment of maternal-fetal Doppler parameters and maternal plasma level of matrix metalloproteinases 2 and 9 [Internet]. The Journal of Maternal-Fetal and Neonatal Medicine. 2016 ; 29( 24): 3967-3970.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3109/14767058.2016.1152247
Vancouver
Jorge Neto SD, Machado JSR, Araújo Júnior E, Palei ACT, Amaral LM, Tanus-Santos JE, Marcolin AC, Duarte G, Sandrim VC, Cavalli R de C. Longitudinal assessment of maternal-fetal Doppler parameters and maternal plasma level of matrix metalloproteinases 2 and 9 [Internet]. The Journal of Maternal-Fetal and Neonatal Medicine. 2016 ; 29( 24): 3967-3970.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3109/14767058.2016.1152247
Artigo de periodico
Circulating microRNA expression profiles in pre-eclampsia: evidence of increased miR-885-5p levels (2016)
Sandrim, V. C.; Luizon, M. R.; Palei, A. C.; Tanus-Santos, José Eduardo; Cavalli, Ricardo de Carvalho
Fonte: BJOG - British Journal of Obstetrics and Gynaecology. Unidade: FMRP
Assuntos: PRÉ-ECLÂMPSIA, GRAVIDEZ, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDRIM, V. C. et al. Circulating microRNA expression profiles in pre-eclampsia: evidence of increased miR-885-5p levels. BJOG - British Journal of Obstetrics and Gynaecology, v. 123, p. 2120-2128, 2016Tradução . . Disponível em: https://doi.org/10.1111/1471-0528.13903. Acesso em: 01 nov. 2024.
APA
Sandrim, V. C., Luizon, M. R., Palei, A. C., Tanus-Santos, J. E., & Cavalli, R. de C. (2016). Circulating microRNA expression profiles in pre-eclampsia: evidence of increased miR-885-5p levels. BJOG - British Journal of Obstetrics and Gynaecology, 123, 2120-2128. doi:10.1111/1471-0528.13903
NLM
Sandrim VC, Luizon MR, Palei AC, Tanus-Santos JE, Cavalli R de C. Circulating microRNA expression profiles in pre-eclampsia: evidence of increased miR-885-5p levels [Internet]. BJOG - British Journal of Obstetrics and Gynaecology. 2016 ; 123 2120-2128.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/1471-0528.13903
Vancouver
Sandrim VC, Luizon MR, Palei AC, Tanus-Santos JE, Cavalli R de C. Circulating microRNA expression profiles in pre-eclampsia: evidence of increased miR-885-5p levels [Internet]. BJOG - British Journal of Obstetrics and Gynaecology. 2016 ; 123 2120-2128.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/1471-0528.13903
Artigo de periodico
Role of adiponectin on antioxidant profile: evaluation during healthy and hypertensive disorders of pregnancy (2016)
Eleuterio, Níbia Mariana; Palei, Ana C. T.; Machado, Jackeline S. Rangel; Tanus-Santos, José Eduardo; Cavalli, Ricardo de Carvalho; Sandrim, Valeria C.
Fonte: Blood Pressure. Unidade: FMRP
Assuntos: ADIPONECTINA, ANTIOXIDANTES, HIPERTENSÃO NA GRAVIDEZ, PRÉ-ECLÂMPSIA, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELEUTERIO, Níbia Mariana et al. Role of adiponectin on antioxidant profile: evaluation during healthy and hypertensive disorders of pregnancy. Blood Pressure, v. 25, n. 4, p. 241-243, 2016Tradução . . Disponível em: https://doi.org/10.3109/08037051.2015.1134550. Acesso em: 01 nov. 2024.
APA
Eleuterio, N. M., Palei, A. C. T., Machado, J. S. R., Tanus-Santos, J. E., Cavalli, R. de C., & Sandrim, V. C. (2016). Role of adiponectin on antioxidant profile: evaluation during healthy and hypertensive disorders of pregnancy. Blood Pressure, 25( 4), 241-243. doi:10.3109/08037051.2015.1134550
NLM
Eleuterio NM, Palei ACT, Machado JSR, Tanus-Santos JE, Cavalli R de C, Sandrim VC. Role of adiponectin on antioxidant profile: evaluation during healthy and hypertensive disorders of pregnancy [Internet]. Blood Pressure. 2016 ; 25( 4): 241-243.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3109/08037051.2015.1134550
Vancouver
Eleuterio NM, Palei ACT, Machado JSR, Tanus-Santos JE, Cavalli R de C, Sandrim VC. Role of adiponectin on antioxidant profile: evaluation during healthy and hypertensive disorders of pregnancy [Internet]. Blood Pressure. 2016 ; 25( 4): 241-243.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3109/08037051.2015.1134550

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada